Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LSAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LY86-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MSRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAW1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TXNDC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF829 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF771 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL20RB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506374 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAGLU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIP2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEXIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELMO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on